logo
  • Home
  • News
Menu

Syros Pharmaceuticals Is A Buy As New Trials Start

Home / Stock Analysis / Syros Pharmaceuticals Is A Buy As New Trials Start
Article feature image

Syros Pharmaceuticals Is A Buy As New Trials Start

20 Nov Stock Analysis

wildpixel/iStock via Getty Images
In the high risk/high reward world of small, clinical stage pharmaceutical companies, one of my favorites is Syros Pharmaceuticals (SYRS). Syros is focused on controlling gene expression as a potential cure for cancers….

Click here to view the original article.

Tags:
Global, Seeking Alpha
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

iag-stock-news-today-dec-13-2025-international-consolidated-airlines-group-sa-share-price-forecasts.webp
+

International Consolidated Airlines Group SA Share Price, Forecasts, Buybacks and Key Catalysts

13 Dec Stock Analysis
52076f0ecb1f027d51c8c6d157907ebb.jpeg
+

Does Public Storage’s 2025 Valuation Reflect Its Recent Share Price Slide?

13 Dec Stock Analysis

recent post

  • iag-stock-news-today-dec-13-2025-international-consolidated-airlines-group-sa-share-price-forecasts.webp

    International Consolidated Airlines Group SA Share

    Dec 13 2025
  • binance-crypto-child-.jpg

    Binance Junior looks safe, but the

    Dec 13 2025
  • 52076f0ecb1f027d51c8c6d157907ebb.jpeg

    Does Public Storage’s 2025 Valuation Reflect

    Dec 13 2025
  • 693d3ebd343726cfdf7a9d98_693d3ebc44d7b98e2e8d5438_lastImage.png

    Crypto Payroll: An Inclusive Approach to

    Dec 13 2025
  • evolution-mining-asx-evn-share-price-near-record-high-todays-news-forecasts-and-analyst-outlook-dec.jpeg

    Today’s News, Forecasts and Analyst Outlook

    Dec 13 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.